Autoimmune diseases are diseases in which the body’s own immune system attacks one or more organ systems in the body resulting in injury to the body and illness. The purpose of this study is to investigate a potential new treatment for autoimmune diseases.
For this initial stage of research, we require healthy participants to assess to safety and tolerability of the medication, how it is absorbed in the bloodstream, and the effect of the medication on the immune system.
Please note there are 5 visits prior to the inpatient stay, which includes 2 screening visits.
This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.
Call us on 1800 243 733 to discuss your eligibility today!